Narya Capital

2019

Founded

12

Investments

United States

Offices

Venture Fund

Investor Type

About

Narya Capital is an early-stage venture capital firm based in Ohio, dedicated to leveraging technology and science to address significant challenges in the Americas. Founded in 2019 by J.D. Vance and Colin Greenspon, the firm focuses on investing in technology companies that tackle critical issues such as healthcare, food production, advanced therapies, defense technologies, and affordable insurance.

Narya Capital's investment thesis spans various sectors, including agriculture, space technology, fintech, and healthcare. The firm typically invests in Seed to Series C rounds, with a particular emphasis on Series A and B investments. Notable portfolio companies include AppHarvest, an agtech firm; True Anomaly, a space technology company; and Kriya Therapeutics, a biotech startup.

Narya Capital's leadership includes partners Colin Greenspon and Falon Donohue. The firm leverages its network of successful investors, entrepreneurs, and institutions to provide long-term capital and support to its portfolio companies, aiming to drive innovation and solve important problems through technology.

Portfolio Companies

AppHarvest, True Anomaly, Kriya Therapeutics, AcreTrader, AmplifyBio, Atomic Industries, Branch Financial, Chapter Medicare, Hallow, Rumble

Gepgraphic Focus

United States

Key Differentiators

Focus on addressing significant challenges in the Americas, Invests in technology companies outside traditional tech hubs, Emphasis on early-stage investments, particularly Series A and B rounds

Thypical Investment Size

$5 to $10 million

Total Funds Raised

$93 million

Visit Website

BioTech

Apps

Health & Wellness

Consumer

InsurTech

Seed

Series A

Series B

Series C

United States